Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease

Robin Dart(Guy's and St Thomas' NHS Foundation Trust), Iva Zlatareva(The Francis Crick Institute), Pierre Vantourout(The Francis Crick Institute), Efstathios Theodoridis(The Francis Crick Institute), Ariella Amar(King's College London), Shichina Kannambath(National Institute for Health and Care Research), Philip East(The Francis Crick Institute), Timothy Recaldin(Gamma Therapeutics (United States)), John Mansfield(Newcastle upon Tyne Hospitals NHS Foundation Trust), Christopher A Lamb(Newcastle upon Tyne Hospitals NHS Foundation Trust), Miles Parkes(University of Cambridge), Peter M. Irving(Guy's and St Thomas' NHS Foundation Trust), Natalie J. Prescott(King's College London), Adrian Hayday(The Francis Crick Institute)
Science
September 14, 2023
Cited by 66Open Access
Full Text

Abstract

Murine intraepithelial γδ T cells include distinct tissue-protective cells selected by epithelial butyrophilin-like (BTNL) heteromers. To determine whether this biology is conserved in humans, we characterized the colonic γδ T cell compartment, identifying a diverse repertoire that includes a phenotypically distinct subset coexpressing T cell receptor Vγ4 and the epithelium-binding integrin CD103. This subset was disproportionately diminished and dysregulated in inflammatory bowel disease, whereas on-treatment CD103 + γδ T cell restoration was associated with sustained inflammatory bowel disease remission. Moreover, CD103 + Vγ4 + cell dysregulation and loss were also displayed by humans with germline BTNL3/BTNL8 hypomorphism, which we identified as a risk factor for penetrating Crohn’s disease (CD). Thus, BTNL-dependent selection and/or maintenance of distinct tissue-intrinsic γδ T cells appears to be an evolutionarily conserved axis limiting the progression of a complex, multifactorial, tissue-damaging disease of increasing global incidence.


Related Papers

No related papers found

Powered by citation graph analysis